Interesting that the FDA had no issue with Jakafi and their statistical methods where they used a lower null hypothesis on their single arm study of 40% and 20% as clinically meaningful effect
Seeking Alpha hatchet job, page-124
-
- There are more pages in this discussion • 98 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
-0.010(0.91%) |
Mkt cap ! $1.250B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.09 | $1.08 | $149.9K | 137.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 143455 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 5190 | 5 |
View Market Depth
| Last trade - 10.06am 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |